<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39323452</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>27</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2220-3249</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>25</Day></PubDate></JournalIssue><Title>World journal of virology</Title><ISOAbbreviation>World J Virol</ISOAbbreviation></Journal><ArticleTitle>Rhabdomyolysis-related acute kidney injury in patients with COVID-19.</ArticleTitle><Pagination><StartPage>91107</StartPage><MedlinePgn>91107</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">91107</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.5501/wjv.v13.i3.91107</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Viral and bacterial infections may be complicated by rhabdomyolysis, which has a spectrum of clinical presentations ranging from asymptomatic laboratory abnormalities to life-threatening conditions such as renal failure. Direct viral injury as well as inflammatory responses may cause rhabdomyolysis in the course of coronavirus disease 2019 (COVID-19). When presented with acute kidney injury (AKI), rhabdomyolysis may be related to higher morbidity and mortality.</AbstractText><AbstractText Label="AIM" NlmCategory="OBJECTIVE">To compare rhabdomyolysis-related AKI with other AKIs during COVID-19.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A total of 115 patients with COVID-19 who had AKI were evaluated retrospectively. Fifteen patients had a definite diagnosis of rhabdomyolysis (<i>i.e.</i>, creatine kinase levels increased to &gt; 5 times the upper normal range with a concomitant increase in transaminases and lactate dehydrogenase). These patients were aged 61.0 ± 19.1 years and their baseline creatinine levels were 0.87 ± 0.13 mg/dL. Patients were treated according to national COVID-19 treatment guidelines. They were compared with patients with COVID-19 who had AKI due to other reasons.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">For patients with rhabdomyolysis, creatinine reached 2.47 ± 1.17 mg/dL during follow-up in hospital. Of these patients, 13.3% had AKI upon hospital admission, and 86.4% developed AKI during hospital follow-up. Their peak C-reactive protein reached as high as 253.2 ± 80.6 mg/L and was higher than in patients with AKI due to other reasons (<i>P</i> &lt; 0.01). Peak ferritin and procalcitonin levels were also higher for patients with rhabdomyolysis (<i>P</i> = 0.02 and <i>P</i> = 0.002, respectively). The mortality of patients with rhabdomyolysis was calculated as 73.3%, which was higher than in other patients with AKI (18.1%) (<i>P</i> = 0.001).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Rhabdomyolysis was present in 13.0% of the patients who had AKI during COVID-19 infection. Rhabdomyolysis-related AKI is more proinflammatory and has a more mortal clinical course.</AbstractText><CopyrightInformation>©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Murt</LastName><ForeName>Ahmet</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Nephrology Clinic, Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Istanbul 34000, Türkiye. ahmet.murt@istanbul.edu.tr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Altiparmak</LastName><ForeName>Mehmet Riza</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Nephrology, Istanbul University, Istanbul 34000, Türkiye.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>World J Virol</MedlineTA><NlmUniqueID>101608353</NlmUniqueID><ISSNLinking>2220-3249</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Creatine kinase</Keyword><Keyword MajorTopicYN="N">Rhabdomyolysis</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>Conflict-of-interest statement: The authors declare that they have no conflict of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>6</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>26</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>26</Day><Hour>10</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>26</Day><Hour>4</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39323452</ArticleId><ArticleId IdType="pmc">PMC11401002</ArticleId><ArticleId IdType="doi">10.5501/wjv.v13.i3.91107</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Giannoglou GD, Chatzizisis YS, Misirli G. The syndrome of rhabdomyolysis: Pathophysiology and diagnosis. Eur J Intern Med. 2007;18:90–100.</Citation><ArticleIdList><ArticleId IdType="pubmed">17338959</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagley WH, Yang H, Shah KH. Rhabdomyolysis. Intern Emerg Med. 2007;2:210–218.</Citation><ArticleIdList><ArticleId IdType="pubmed">17909702</ArticleId></ArticleIdList></Reference><Reference><Citation>Haroun MW, Dieiev V, Kang J, Barbi M, Marashi Nia SF, Gabr M, Eman G, Kajita G, Swedish K. Rhabdomyolysis in COVID-19 Patients: A Retrospective Observational Study. Cureus. 2021;13:e12552.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7869906</ArticleId><ArticleId IdType="pubmed">33575135</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadim MK, Forni LG, Mehta RL, Connor MJ Jr, Liu KD, Ostermann M, Rimmelé T, Zarbock A, Bell S, Bihorac A, Cantaluppi V, Hoste E, Husain-Syed F, Germain MJ, Goldstein SL, Gupta S, Joannidis M, Kashani K, Koyner JL, Legrand M, Lumlertgul N, Mohan S, Pannu N, Peng Z, Perez-Fernandez XL, Pickkers P, Prowle J, Reis T, Srisawat N, Tolwani A, Vijayan A, Villa G, Yang L, Ronco C, Kellum JA. COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup. Nat Rev Nephrol. 2020;16:747–764.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7561246</ArticleId><ArticleId IdType="pubmed">33060844</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed MMB, Lukitsch I, Torres-Ortiz AE, Walker JB, Varghese V, Hernandez-Arroyo CF, Alqudsi M, LeDoux JR, Velez JCQ. Acute Kidney Injury Associated with Coronavirus Disease 2019 in Urban New Orleans. Kidney360. 2020;1:614–622.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8815549</ArticleId><ArticleId IdType="pubmed">35372932</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirsch JS, Ng JH, Ross DW, Sharma P, Shah HH, Barnett RL, Hazzan AD, Fishbane S, Jhaveri KD Northwell COVID-19 Research Consortium; Northwell Nephrology COVID-19 Research Consortium. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. 2020;98:209–218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7229463</ArticleId><ArticleId IdType="pubmed">32416116</ArticleId></ArticleIdList></Reference><Reference><Citation>Zager RA. Studies of mechanisms and protective maneuvers in myoglobinuric acute renal injury. Lab Invest. 1989;60:619–629.</Citation><ArticleIdList><ArticleId IdType="pubmed">2716281</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumura Y, Sugiyama T, Kondo N, Miyahara M, Hanaoka N, Nagashima H, Kasahara Y, Fujiyoshi N, Inada A, Inaba S. Fluid restriction management in the treatment of COVID-19: a single-center observational study. Sci Rep. 2022;12:17339.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9569332</ArticleId><ArticleId IdType="pubmed">36243779</ArticleId></ArticleIdList></Reference><Reference><Citation>Murt A, Dinçer MT, Karaca C, Trabulus S, Karaali R, Balkan II, Seyahi N, Altıparmak MR. Acute Kidney Injury in Cases of COVID-19 Without ExistingKidney Disease: Does It Differ at Various Stages of the Disease? Cerrahpaşa Med J. 2022:1–9.</Citation></Reference><Reference><Citation>Robbins-Juarez SY, Qian L, King KL, Stevens JS, Husain SA, Radhakrishnan J, Mohan S. Outcomes for Patients With COVID-19 and Acute Kidney Injury: A Systematic Review and Meta-Analysis. Kidney Int Rep. 2020;5:1149–1160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7314696</ArticleId><ArticleId IdType="pubmed">32775814</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin M, Tong Q. Rhabdomyolysis as Potential Late Complication Associated with COVID-19. Emerg Infect Dis. 2020;26:1618–1620.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7323559</ArticleId><ArticleId IdType="pubmed">32197060</ArticleId></ArticleIdList></Reference><Reference><Citation>Inciardi RM, Adamo M, Lupi L, Cani DS, Di Pasquale M, Tomasoni D, Italia L, Zaccone G, Tedino C, Fabbricatore D, Curnis A, Faggiano P, Gorga E, Lombardi CM, Milesi G, Vizzardi E, Volpini M, Nodari S, Specchia C, Maroldi R, Bezzi M, Metra M. Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. Eur Heart J. 2020;41:1821–1829.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7239204</ArticleId><ArticleId IdType="pubmed">32383763</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodríguez E, Soler MJ, Rap O, Barrios C, Orfila MA, Pascual J. Risk factors for acute kidney injury in severe rhabdomyolysis. PLoS One. 2013;8:e82992.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3867454</ArticleId><ArticleId IdType="pubmed">24367578</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippi G, Plebani M. Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis. Clin Chim Acta. 2020;505:190–191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7094472</ArticleId><ArticleId IdType="pubmed">32145275</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>